FDA Approved: DICLOFENAC POTASSIUM — Supplemental Application (Trifluent Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for Diclofenac potassium from Trifluent Pharma LLC as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Migraine
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• DICLOFENAC POTASSIUM (diclofenac potassium)

Snippet

SUPPL AP for DICLOFENAC POTASSIUM (DICLOFENAC POTASSIUM)